Loading...
XASX
PME
Market cap21bUSD
Jul 08, Last price  
314.20AUD
1D
1.36%
1Q
66.87%
Jan 2017
6,445.83%
IPO
22,834.31%
Name

Pro Medicus Ltd

Chart & Performance

D1W1MN
P/E
396.43
P/S
203.32
EPS
0.79
Div Yield, %
0.13%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
26.36%
Revenues
161m
+29.25%
10,276,00011,298,00012,539,0009,157,0009,940,00019,197,00013,969,00011,313,00011,154,00014,268,00017,490,00027,521,00031,597,00033,872,00050,105,00056,821,00067,884,00093,461,000124,900,000161,429,000
Net income
83m
+36.52%
5,493,0006,115,0007,052,0007,933,0005,683,0003,920,000503,0001,791,0005,131,0001,509,0003,217,0006,368,0009,321,0009,965,00019,125,00023,076,00030,850,00044,442,00060,648,00082,794,000
CFO
87m
+33.97%
4,461,0006,910,0005,805,0008,810,0005,477,0006,839,0006,250,0005,876,0003,813,0004,233,0004,183,00011,254,00014,829,00013,873,00024,658,00031,592,00039,020,00062,225,00064,772,99986,776,000
Dividend
Sep 04, 20240.22 AUD/sh
Earnings
Aug 12, 2025

Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
IPO date
Oct 10, 2000
Employees
79
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
161,429
29.25%
124,900
33.64%
Cost of revenue
72,466
44,313
Unusual Expense (Income)
NOPBT
88,963
80,587
NOPBT Margin
55.11%
64.52%
Operating Taxes
33,704
25,478
Tax Rate
37.89%
31.62%
NOPAT
55,259
55,109
Net income
82,794
36.52%
60,648
36.47%
Dividends
(36,554)
(26,108)
Dividend yield
0.24%
0.38%
Proceeds from repurchase of equity
(2,769)
(845)
BB yield
0.02%
0.01%
Debt
Debt current
553
1,425
Long-term debt
3,585
2,394
Deferred revenue
25,850
23,421
Other long-term liabilities
113
77
Net debt
(162,479)
(120,037)
Cash flow
Cash from operating activities
86,776
64,773
CAPEX
(6,693)
(6,446)
Cash from investing activities
(78,074)
(9,795)
Cash from financing activities
(39,841)
(27,527)
FCF
54,168
39,901
Balance
Cash
155,425
121,495
Long term investments
11,192
2,361
Excess cash
158,546
117,611
Stockholders' equity
187,728
138,776
Invested Capital
57,214
46,514
ROIC
106.55%
145.84%
ROCE
39.82%
46.87%
EV
Common stock shares outstanding
104,652
104,588
Price
143.26
118.25%
65.64
55.36%
Market cap
14,992,499
118.39%
6,865,133
55.37%
EV
14,830,020
6,745,096
EBITDA
97,473
88,513
EV/EBITDA
152.14
76.20
Interest
Interest/NOPBT